Bruce P Neri

USPTO Granted Patents = 40 (Patent Applications = 7)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 5.4

ph-index = 25

Forward Citations = 1,312(Granted Patents)

Location History:

Madison, WI (US) (2001 - 2011)
Cary, NC (US) (2013)
Carlsbad, CA (US) (2006 - 2019)

Company Filing History:

30 out of 102

Third Wave Technologies, Inc.

patents

4 out of 22

Prometheus Laboratories Inc.

Northwestern University

patents

5. 1 out of 1,150

Societe Des Produits Nestle S.a.

patents

Years Active: 2001-2019

Loading Chart...

40 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10436786 - Methods for detecting truncated receptors using antibody-based arrays (2019-10-08),

2. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays (2016-03-01),

3. 8609349 - Drug selection for breast cancer therapy using antibody-based arrays (2013-12-17),

4. 8609336 - Detection of small nucleic acids (2013-12-17),

5. 8315818 - Methods of diagnosing inflammatory bowel disease (2012-11-20),

6. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays (2012-04-24),

7. 8063184 - RNA detection assays (2011-11-22),

8. 7943328 - Method and system for assisting in diagnosing irritable bowel syndrome (2011-05-17),

9. 7935800 - RNA detection assays (2011-05-03),

10. 7908091 - Methods of predicting and monitoring tyrosine kinase inhibitor therapy (2011-03-15),

11. 7873479 - Methods of diagnosing inflammatory bowel disease (2011-01-18),

12. 7851150 - Detection of small nucleic acids (2010-12-14),

13. 7824862 - Methods for analyzing nucleic acid (2010-11-02),

14. 7820387 - Reactions on a solid surface (2010-10-26),

15. 7807806 - RNA detection assays (2010-10-05),

Title: Bruce P. Neri: Innovator in Cancer Detection Technologies

Introduction

Bruce P. Neri, based in Madison, WI, is a prolific inventor with a remarkable portfolio of 40 patents. His work primarily focuses on innovative solutions in the field of cancer diagnosis and treatment, employing advanced methodologies and antibody-based technologies to enhance patient outcomes.

Latest Patents

Among his latest patents are significant advancements in detecting truncated receptors through antibody-based arrays. This invention provides valuable compositions and methods for identifying the activation states of components in signal transduction pathways within tumor cells. The information gained can play a crucial role in cancer diagnosis, prognosis, and the design of targeted cancer treatments. Another noteworthy patent addresses drug selection for breast cancer therapy, utilizing similar antibody-based arrays to facilitate more effective therapeutic strategies.

Career Highlights

Bruce has made significant contributions during his tenure at various renowned organizations, including Third Wave Technologies, Inc. and Prometheus Laboratories Inc. His expertise and innovative spirit have propelled advancements in the field, making him a notable figure among his peers.

Collaborations

Throughout his career, Bruce has collaborated with notable professionals in the industry, including Victor I. Lyamichev and Jeff G. Hall. These collaborations have fostered a rich environment for innovation and have contributed to the successful development of his groundbreaking technologies.

Conclusion

In summary, Bruce P. Neri has established himself as a key inventor in the realm of cancer detection and treatment methodologies. His 40 patents reflect his dedication to advancing medical science, ultimately leading to improved diagnostic and therapeutic options for cancer patients. Through his work and collaborations, Bruce continues to make strides that have the potential to enhance the landscape of cancer care.

This text is generated by artificial intelligence and may not be accurate.